Iterum Therapeutics plc Gains 97.75%
Mon, Mar 30, 2026 at 07:26 PM
Iterum Therapeutics plc (ITRM:NASDAQ) jumped higher at $0.07, representing a gain of 97.8%. The stock got featured on our News Catalysts scanner on Sat, Mar 28, 2026 at 09:45 PM in the 'MISCELLANEOUS' category. From Mon, Mar 16, 2026, the stock recorded 30.00% Up Days and 27.27% Green Days
About Iterum Therapeutics plc (ITRM:NASDAQ)
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally.
Top 10 Gainers:
- PMGC Holdings Inc. (ELAB:NASDAQ), 113.17%
- Bullfrog AI Holdings, Inc. (BFRG:NASDAQ), 106.57%
- Astrotech Corporation (ASTC:NASDAQ), 105.3%
- Iterum Therapeutics plc (ITRM:NASDAQ), 97.75%
- Perfect Moment Ltd. Common Stock (PMNT:NYSEMKT), 74.73%
- JE Cleantech Holdings Limited (JCSE:NASDAQ), 72%
- Southland Holdings, Inc. (SLND:NYSEMKT), 47.54%
- Jeffs' Brands Ltd (JFBR:NASDAQ), 40%
- Greenland Energy Company (GLND:NASDAQ), 37.15%
- SeaStar Medical Holding Corporation (ICU:NASDAQ), 32.12%